SEO URLwww.firestrike.ai/deals/organon-sun-pharma-acquisition-2026-2
acquisitionAnnounced · Apr 28, 2026pharmaceuticalsSource · CredibleArticle · Factual
Sun Pharma acquires Organon
David Najork · Founding Software Engineer
Announced · Updated · 1 min read
Deal value
$10B
Target
Organon
Jersey City, New Jersey
Acquirer
Sun Pharma
Full Acquisition
Status
Pending
Sun Pharma agreed to acquire Organon. Reported deal value: $10B. Status: Pending. Sector: pharmaceuticals. Target headquarters context: Jersey City, New Jersey, United States.
This page summarizes publicly available information about the transaction as of 2026-04-28. Figures and status may change as filings and press coverage update.
0:00 Key Takeaways Sun Pharma will pay $14.00 per share cash for Organon , targeting early-2027 close subject to regulatory and shareholder approvals, in what is positioned as India largest pharma deal
Deal timeline
Announced
Apr 28, 2026 · pharmexec.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context
This transaction is classified in pharmaceuticals with a reported deal value of $10B. Figures and status may change as sources update.
Sources: pharmexec.com · Primary article · FireStrike proprietary index